Ropharma is indirectly owned by local businessman Mihai Miron. Cyprus-registered ADD Pharmaceuticals holds a 22.55% stake, while Rimia Investments holds 21.43%. Other shareholders include Arrow Pharmaceuticals with 31.31% and Romania’s privatization authority AVAS with 0.33%.
The company reported total sales of 99.96 million lei (EUR23.6 million) in the first quarter, up 15% on the year.
Ropharma has a share capital of RON29.1 million, divided into 291 million shares with a face value of RON0.1.
Wednesday, Ropharma closed up 1.27% at RON0.88 a share.